Nancy C. Andrews - 21 May 2025 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Role
Director
Signature
/s/ Nancy C. Andrews
Issuer symbol
CRL
Transactions as of
21 May 2025
Net transactions value
+$407,910
Form type
4
Filing time
23 May 2025, 16:08:31 UTC
Previous filing
30 Jan 2025
Next filing
24 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Andrews Nancy C Director C/O CHARLES RIVER LABORATORIES, 251 BALLARDVALE STREET, WILMINGTON /s/ Nancy C. Andrews 23 May 2025 0001804999

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRL Common Stock Award $127,691 +946 +31% $134.98 3,964 21 May 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRL Stock Options (Right to Buy) Award $280,218 +2,076 $134.98 2,076 21 May 2025 Common Stock 2,076 $134.98 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The unvested restricted stock units vest upon the earlier of 5/21/2026 or the business day prior to the Company's next annual meeting of shareholders.
F2 The stock options become exercisable upon the earlier of 5/21/2026 or the business day prior to the Company's next annual meeting of shareholders.